👏 Great paper from Emma Scott, Jennifer Munkley, and Co in Journal Of Pathology showing that ST6GAL1 and sialylation of N-glycans links to #prostatecancer progression! Could inhibiting ST6GAL1 reduce prostate cancer growth and spread 🤔? Grab a ☕ and see here: bit.ly/3qtMn2s

🍬🍬

📢 Did you know overexpression of GCNT1 promotes the growth of prostate tumours and can change cell surface glycosylation? 🎯 Grab a ☕ and click this link: go.nature.com/3s4rKKQ 👏 Fab work from Jennifer Munkley and Newcastle University team publishing in Scientific Reports 👏

Successfully defended my PhD thesis and Dr Garnham it is. Thank you to my amazing supervisor for your support along the way! You have been the best Emma Scott

So so proud of the Dr Rebecca Garnham the first glyco-immunology PhD student to pass her viva from the group. Huge congratulations 🎉

Congratulations Dr Garnham Rebecca Garnham on a fantastic thesis and PhD defence! Wishing you and Emma Scott a very well deserved evening of celebrations 🎉

Super proud of Rebecca Garnham for her part in organising the NUCancer PGR conference. Looks like a brilliant day!

Just over a week left to apply for this funded PhD position in our group. An opportunity for an interdisciplinary translational cancer research project! @NUBiosciences DiMeN DTP Newcastle University Centre for Cancer Cells, Genes and Molecules - Newcastle

Nice work by Flavio Schwarz and his team at InterVenn Biosciences showing that PD-1 blocking antibodies depend on PD-1 glycosylation. #glycotime Variable PD-1 glycosylation modulates the activity of immune checkpoint inhibitors life-science-alliance.org/content/7/3/e2…

Congratulations to Emma Scott, Rebecca Garnham, and team! Such a star-studded line of authors!! 🤩 We'll grab a coffee and have a good read! ☕️

Congratulations @RebeccaGarnham and Emma Scott! Very nice! FYI ST3GAL1 is also really important in #myeloma! Strategies to target sialyltransferases and/or hypersialylation in #cancer should be pursued. Palleon Pharma Michael Anthony Carolyn Bertozzi Aideen Ryan

Today we're announcing further details of our £42million TRANSFORM screening trial. It will bring together six of the world's leading prostate cancer researchers and has the potential to reduce prostate cancer deaths by 40%. ➡️ Find out more: bit.ly/3xSHfYS

Third and final graduation! The end of an era for me, but looking forward to attending the graduations of my future students 🎓